Intraperitoneal Copper-Manganese Nanozyme Suppresses Peritoneal Metastasis with Antitumor Immune Activation.

Jinquan Zhang, Zhenze Xie, Muye He, Siqi He, Ling Wang, Chengxiao Song, Jingguang Wang, Jian Li, Chang Du, Ruoxu Dou

Abstract read

In one paragraph

Article in Biomaterials research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jinquan ZhangDepartment of Hepatobiliary Surgery, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, Guangdong 519000, PR China.ORCID https://orcid.org/0009-0005-8387-7637

Zhenze XieDepartment of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, PR China.

Muye HeDepartment of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, PR China.

Siqi HeComprehensive Cancer Center, Foresea Life Insurance Guangzhou General Hospital, Guangzhou, Guangdong 511300, PR China.

Ling WangDepartment of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, PR China.

Chengxiao SongDepartment of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, PR China.ORCID https://orcid.org/0009-0005-6084-3653

Jingguang WangDepartment of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, PR China.ORCID https://orcid.org/0009-0000-7743-6513

Jian LiDepartment of Hepatobiliary Surgery, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, Guangdong 519000, PR China.

Chang DuDepartment of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, PR China.ORCID https://orcid.org/0000-0002-6460-0764

Ruoxu DouComprehensive Cancer Center, Foresea Life Insurance Guangzhou General Hospital, Guangzhou, Guangdong 511300, PR China.ORCID https://orcid.org/0000-0002-6572-1664

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peritoneal metastasis from colorectal cancer (CRC) carries a dismal prognosis, and current surgical and medical therapies achieve limited efficacy with high recurrence rates. Here, we developed a copper-manganese-based nanozyme (CM) that integrated MnO

Identifiers

PMID42719306

DOI10.34133/bmr.0401

PMCPMC13554416

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.